Literature DB >> 8104475

Herpes virus saimiri-transformed human T lymphocytes: normal functional phenotype and preserved T cell receptor signalling.

H W Mittrücker1, I Müller-Fleckenstein, B Fleckenstein, B Fleischer.   

Abstract

Herpes virus saimiri (HVS), a primate herpes virus, transforms human CD4+ and CD8+ T lymphocytes to continuous growth in vitro. We have previously shown that HVS-transformed human T cells (HVS-T cells) respond to stimulation via CD2 with autocrine growth. In the present study we have investigated the functional characteristics of HVS-T cells. We describe that these cells can perform all the functions of normal T cells, i.e. cytokine secretion, cytotoxicity, and exocytosis of granule esterases. All these activities can be triggered via CD2 by binding to its natural ligand or via the TCR, e.g. by anti-TCR antibodies, by recognition of a bacterial superantigen and by MHC-restricted recognition of specific antigen. The pattern of tyrosine-phosphorylated proteins after TCR triggering was identical in HVS-T cells and normal T cells. We conclude that HVS-T cells can respond to TCR-mediated signals with the functions of normal T lymphocytes. Furthermore, HVS-T cells are the only transformed human T cells that can be specifically triggered by cytotoxicity and esterase release. The finding that the TCR functions normally in these cells will make HVS a convenient means to immortalize antigen-specific human T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104475     DOI: 10.1093/intimm/5.8.985

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

Review 1.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  Herpesvirus saimiri.

Authors:  H Fickenscher; B Fleckenstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells.

Authors:  A Knappe; C Hiller; M Thurau; S Wittmann; H Hofmann; B Fleckenstein; H Fickenscher
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.

Authors:  Jinzhu Li; Sarah K Figueira; Alexandra C A Vrazo; Brock F Binkowski; Braeden L Butler; Yasuhiro Tabata; Alexandra Filipovich; Michael B Jordan; Kimberly A Risma
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

5.  Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri.

Authors:  A Knappe; S Hör; S Wittmann; H Fickenscher
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Downregulation of p56(lck) tyrosine kinase activity in T cells of squirrel monkeys (Saimiri sciureus) correlates with the nontransforming and apathogenic properties of herpesvirus saimiri in its natural host.

Authors:  T Greve; G Tamgüney; B Fleischer; H Fickenscher; B M Bröker
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes.

Authors:  H Fickenscher; B Biesinger; A Knappe; S Wittmann; B Fleckenstein
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.

Authors:  K Saha; G Bentsman; L Chess; D J Volsky
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Immortalization of human T cells expressing T-cell receptor gamma delta by herpesvirus saimiri.

Authors:  M Yasukawa; Y Inoue; N Kimura; S Fujita
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.